The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Data from the ATLAS research comprises a series of trials that have yielded years of long-term, comprehensive data on safety ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...